Results 11 to 20 of about 25,866 (234)

Cardiac resynchronization therapy

Current Treatment Options in Cardiovascular Medicine, 2008
It is now well established that electrical and mechanical dyssynchrony are not clinically synonymous; however, at present no individual noninvasive method can reliably and consistently identify the criteria for mechanical dysfunction correctable through device therapy. The results of the PROSPECT (Predictors of Response to CRT) trial not only highlight
Daniel M, Couri, Sunil, Mankad
  +6 more sources

The Use of Machine Learning Algorithms in the Evaluation of the Effectiveness of Resynchronization Therapy

Journal of Cardiovascular Development and Disease, 2022
Background: Cardiovascular disease remains the leading cause of death in the European Union and worldwide. Constant improvement in cardiac care is leading to an increased number of patients with heart failure, which is a challenging condition in terms of
Bartosz Krzowski, Jakub Rokicki, Renata Główczyńska, Nikola Fajkis-Zajączkowska, Katarzyna Barczewska, Mariusz Mąsior, Marcin Grabowski, Paweł Balsam   +7 more
doaj   +1 more source

Cardiac Resynchronization Therapy

Journal of the American College of Cardiology, 2009
Congestive heart failure (CHF) has become a major health problem. Despite improved pharmacologic therapies, refractory symptoms and high mortality remain a challenge in such patients. There has been increased interest in the application of ancillary nonpharmacologic therapies for CHF management, such as implantable pacemakers, defibrillators, and/or ...
Cleland, John G.F., Tavazzi, Luigi, Daubert, Jean-Claude, Tageldien, Ahmed, Freemantle, Nick   +4 more
  +5 more sources

Superresponse to Cardiac Resynchronization Therapy [PDF]

Circulation, 2014
Case presentation : A 55-year-old female patient underwent implantation of a cardiac resynchronization therapy (CRT) defibrillator 6 years ago owing to nonischemic dilated cardiomyopathy. Her left-ventricular (LV) ejection fraction (EF) was 28% before implantation, her LV end-diastolic volume index (EDVI) was 144 mL/m2, and her LV end-systolic volume ...
Steffel, Jan, Ruschitzka, Frank
openaire   +3 more sources

Cardiac Resynchronization Therapy Upgrade [PDF]

Circulation: Arrhythmia and Electrophysiology, 2017
The implant rates of cardiac resynchronization therapy (CRT) increased rapidly through the first decade of this millennium but have plateaued more recently and may even have started to decrease in Europe and the United States.1,2 The upgrade of existing pacemakers and implantable cardioverter defibrillators (ICDs) to CRT currently accounts for a ...
Anoop K, Shetty, Christopher A, Rinaldi
openaire   +2 more sources

Predictors of clinical outcomes after cardiac resynchronization therapy in patients ≥75 years of age: a retrospective cohort study

BMC Geriatrics, 2019
Background Cardiac resynchronization therapy has been shown to benefit selected patients with heart failure and reduced ejection fraction. Older patients have been underrepresented in randomized trials.
Laure Champ-Rigot, Anne-Laure Cornille, Pierre Ollitrault, Arnaud Pellissier, Mathieu Chequel, Damien Legallois, Paul Milliez   +6 more
doaj   +1 more source

Infection and migration incidence of cardiac implantable electrical devices in Japan: Web‐based survey results

Journal of Arrhythmia, 2020
Web‐based survey was conducted for experiences of cardiac implantable electrical device (CIED) infection and migration in Japan. A total of 155 cardiologists’ answer was collected in January, 2018.
Hiroshi Nakajima, Nobuhiro Nishii
doaj   +1 more source

Atrioventricular Node Ablation to Enhance Resynchronization Therapy Response in a Patient With Complete Atrioventricular Block

JACC: Case Reports, 2021
Up to one-third of patients who undergo cardiac resynchronization therapy do not obtain clinical benefit. A systematic approach can identify treatable causes in many nonresponding patients.
Axel Sarrias, MD, Damià Pereferrer, MD, Victor Bazan, MD, PhD, Felipe Bisbal, MD, PhD, Raquel Adeliño, MD, Júlia Aranyó, MD, Francisco Gual, MD, Roger Villuendas, MD, Antoni Bayés-Genís, MD, PhD   +8 more
doaj   +1 more source

Cardiac-Resynchronization Therapy

New England Journal of Medicine, 2011
Systolic heart failure is a major problem for Americans today, with 550,000 new cases diagnosed per year, and ultimately contributes to 287,000 deaths annually. While pharmacologic therapy has drastically improved outcomes in patients with systolic heart failure, hospitalizations from systolic heart failure continue to increase and remain a major cost ...
Robert S, Rosenstein, David, Parra
openaire   +5 more sources

Left cardiac atrioventricular delay and inter-ventricular delay in cardiac resynchronization therapy responder and non-responder

Current Directions in Biomedical Engineering, 2016
Cardiac resynchronization therapy is an established therapy for heart failure patients. The aim of the study was to evaluate electrical left cardiac atrioventricular delay and interventricular desynchronization in sinus rhythm cardiac resynchronization ...
Heinke Matthias, Kühnert Helmut, Heinke Tobias, Tumampos Jonas, Dannberg Gudrun   +4 more
doaj   +1 more source